SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
230 hedge funds and large institutions have $3.26B invested in Sage Therapeutics in 2020 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 72 increasing their positions, 75 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
6% more funds holding
Funds holding: 216 → 230 (+14)
0.81% less ownership
Funds ownership: 104.05% → 103.25% (-0.81%)
4% less repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 75
Holders
230
Holding in Top 10
7
Calls
$59.6M
Puts
$27M
Top Buyers
| 1 | +$57.6M | |
| 2 | +$25.8M | |
| 3 | +$20.8M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
+$15.3M |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$13.8M |
Top Sellers
| 1 | -$38.4M | |
| 2 | -$22.4M | |
| 3 | -$21.8M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$20.7M |
| 5 |
Two Sigma Investments
New York
|
-$18.6M |